Sunesis Pharmaceuticals's competitors

Sunesis Pharmaceuticals's competitors include Seattle Genetics, Cleave Biosciences, Innocare and FLX Bio
Add company...
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Seattle Genetics
Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells.
Cleave Biosciences
Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.
Innocare
InnoCare is a biopharmaceutical company aimed to discover and develop novel treatment for cancer and autoimmune diseases.
FLX Bio
FLX Bio is a biopharmaceutical company focused on the discovery, development and commercialization of novel immuno-oncology agents.
Founding Date
Founding Date
1987
Founding Date
1998
Founding Date
2010
Founding Date
N/A
Founding Date
2015
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Bothell, US HQ
Zug, CH
Locations
Burlingame, US HQ
Locations
Haidian, CN HQ
Pudong Xinqu, CN
Nanjing, CN
Locations
South San Francisco, US HQ
Employees
Employees
37
Employees
890
Employees
14
Employees
6
Employees
58
Valuation ($)
Valuation ($)
141.4 m
Valuation ($)
7.8 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 26m (over 1 year ago)
Latest funding round
$ 55m (9 days ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 117m
Total funding raised
$ 55m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles